Stock Market Reviews

CRL (Charles River Laboratories International, Inc.) News

Get the latest news, insights, and market updates on CRL (Charles River Laboratories International, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
  While the top- and bottom-line numbers for Charles River (CRL) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
  Nov 5, 2025 - $CRL
• CRL's Q3 Earnings Top Estimates, Revenues Decline Y/Y, Stock Falls
  Charles River beats Q3 profit and revenue forecasts but posts year-over-year declines and narrows its 2025 outlook.
  Nov 5, 2025 - $CRL
• Charles River Laboratories (CRL) Q3 Earnings and Revenues Surpass Estimates
  Charles River (CRL) delivered earnings and revenue surprises of +4.74% and +2.06%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
  Nov 5, 2025 - $CRL
• Charles River: Q3 Earnings Snapshot
  CRL) on Wednesday reported third-quarter profit of $54.4 million. The Wilmington, Massachusetts-based company said it had profit of $1.10 per share. Earnings, adjusted for non-recurring costs, came to $2.43 per share.
  Nov 5, 2025 - $CRL
• Why Charles River Laboratories (CRL) Shares Are Getting Obliterated Today
  Shares of lab services company Charles River Laboratories (NYSE:CRL) fell 5.8% in the morning session after the company reported third-quarter results that revealed significant underlying weaknesses.
  Nov 5, 2025 - $CRL
• Charles River Laboratories’s (NYSE:CRL) Q3: Beats On Revenue
  Lab services company Charles River Laboratories (NYSE:CRL) announced better-than-expected revenue in Q3 CY2025, but sales were flat year on year at $1.00 billion. Its non-GAAP profit of $2.43 per share was 3.9% above analysts’ consensus estimates.
  Nov 5, 2025 - $CRL
• Charles River Laboratories Announces Third-Quarter 2025 Results
  WILMINGTON, Mass., November 05, 2025--Charles River Laboratories Announces Third-Quarter 2025 Results
  Nov 5, 2025 - $CRL
• Charles River Laboratories International Inc (CRL) Q3 2025 Earnings Call Highlights: Strategic ...
  Despite a slight revenue decline, CRL focuses on strategic initiatives and cost savings to drive long-term growth and shareholder value.
  Nov 5, 2025 - $CRL
• Charles River Laboratories Provides Update on Strategic Review
  WILMINGTON, Mass., November 05, 2025--Charles River Laboratories Provides Update on Strategic Review
  Nov 5, 2025 - $CRL
• Charles River Laboratories to Sell Underperforming, Non-Core Businesses
  Charles River Laboratories International (CRL) said Wednesday it plans to sell certain underperformi
  Nov 5, 2025 - $CRL